Team:GeorgiaTech/Abstract

From 2011.igem.org

(Difference between revisions)
 
Line 10: Line 10:
<center><b>Abstract:</b></center>
<center><b>Abstract:</b></center>
<br>
<br>
-
The ultimate goal of our project was to utilize this system as a mobile gene targeting system capable of eliminating antibiotic resistance. The protoype construct, pSTINGER, was designed for quantitative modeling, proof of concept, and vaccination on a single plasmid. As a result of experimental error, intellectual property agreements, material availability, our biobrick constructs remain experimentally theoretical, though we have modeled our system in various scenarios.  
+
The ultimate goal of our project was to utilize this system as a mobile gene targeting system capable of eliminating antibiotic resistance. The protoype construct, pSTINGER, was designed for quantitative modeling, proof of concept, and vaccination on a single plasmid. As a result of experimental error, intellectual property agreements, material availability, our biobrick constructs remain experimentally theoretical, though we have rigorously modeled our system in various scenarios.  
</font>
</font>
</head>
</head>
</html>
</html>

Latest revision as of 03:44, 29 September 2011

Title: De Novo Adaptation of Streptococcus thermophilus CRISPR1 Defense in E. coli


Abstract:

The ultimate goal of our project was to utilize this system as a mobile gene targeting system capable of eliminating antibiotic resistance. The protoype construct, pSTINGER, was designed for quantitative modeling, proof of concept, and vaccination on a single plasmid. As a result of experimental error, intellectual property agreements, material availability, our biobrick constructs remain experimentally theoretical, though we have rigorously modeled our system in various scenarios.